smTrends
最終更新日時:

Metformin Recall ニュース

"Metformin Recall" に関連する最新 () のニュースをご覧いただけます。

Metformin Recall ニュース

様々なウェブサイトにて "Metformin Recall" に関連する最新 () のニュースをご覧いただけます。

Metformin Recall
5 days ago - FDA Updates and Press Announcements on NDMA in Metformin - FDA Updates and Press Announcements on NDMA in Metformin - www.fda.gov

Metformin Recall
5 days ago - Search list of recalled metformin products - Find out which specific metformin products are affected by the recall - www.fda.gov

Metformin Recall
4 days ago - Several More Companies Recall Metformin ER; Metformin Still Available, However - Despite the recall of several different manufacturers’ formulations of ER metformin because of higher than acceptable levels of NDMA, a potentially carcinogen, experts said patients and providers should experience no significant disruptions in access to therapy. - www.pharmacypracticenews.com

Metformin Recall
1 day ago - Metformin Recalls Continue Due to NDMA Contamination - GoodRx - The FDA found higher than acceptable levels of NDMA, a probable carcinogen, in the popular diabetes medication metformin ER. In response, several pharmaceutical companies began recalls. If you take metformin ER, speak to your doctor before you stop taking it. - www.goodrx.com

Metformin Recall
5 days ago - Contaminated Metformin Hydrochloride Extended-Release Tablets recalled - Lupin Pharmaceuticals, Inc. is recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg at the consumer level. Certain tested batches were above the acceptable daily intake limit - www.northcentralpa.com

Metformin Recall
8 Jul 2020 - More metformin recalled for NDMA; 6 firms now affected - Two manufacturers have announced voluntary recalls of metformin formulations containing elevated levels of a potential carcinogen.<br />   - www.raps.org

Metformin Recall
3 Jul 2020 - Granules Pharmaceuticals Inc. recalls 12 lots of Metformin Hydrochloride ER Tabletss - Read more about Granules Pharmaceuticals Inc. recalls 12 lots of Metformin Hydrochloride ER Tablets on Business-standard. Granules' test results showed NDMA levels above the FDA acceptable limit in one (1) out of the twelve (12) batches distributed to the US market. All other batches continue to remain within the specifications. Out of abundance of caution Granules Pharmaceuticals, Inc. has decided to voluntarily recall all twelve (12) of the distributed lots within expiry of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg from the market. - www.business-standard.com

Metformin Recall
4 days ago - Another pharma maker recalls metformin over NDMA - Five other manufacturers have recalled the popular diabetes medication due to the presence of a the carcinogenic ingredient. - www.formularywatch.com

Metformin Recall
2 days ago - Companies Recall Extended-Release Metformin due to Cancer-Causing Substance - The FDA announced that six companies have voluntarily recalled their extended release metformin due to the possibility that it includes unsafe levels of NDMA, a toxic substance - diatribe.org

29 Jun 2020 - Recent Voluntary Drug Recall of Metformin ER Tablets - Commercial products (including Tufts Health Freedom Plan), Tufts Health Public Plans products - tuftshealthplan.com

Metformin Recall
19 Jun 2020 - Ministry advises of recall of some extended-release metformin drugs - The Ministry of Health is advising the public of the recall of specific batches of named brands of&nbsp;extended-release metformin drugs. In a&nbsp;statement issued on - www.looptt.com

Metformin Recall
9 Jul 2020 - Recall of metformin formulations in the US by Lupin may hit profitability - While Lupin said it expects to relaunch the products, there could still be an impact as it could lose market share - www.livemint.com

18 Jun 2020 - New recall to metformin tablets - Health Canada advises of a new recall to certain lots of metformin medication due to presence or possible presence of NDMA. - www.diabetes.ca

10 Jul 2020 - Drugmakers Recall Metformin for NDMA Contamination - Type 2 Diabetes drug metformin is the latest medicine to be recalled due to unacceptable levels of the probable human carcinogen NDMA (N-Nitrosodimethylamine). - www.fdanews.com

リコール 急上昇ワード

"Metformin Recall" 等、 "リコール" に関連する最新 () の急上昇ワードをご覧いただけます。